Turing Pharmaceuticals (Intranasal Ketamine Program)

Business Data, Corporate Office and Headquarter Address

About

Turing Pharmaceuticals (Intranasal Ketamine Program) is Buildings and Property in United States that focus on drug research program business. Founded in 2015. They cover business area such as post-traumatic stress disorder, suicidality, ketamine, medical office, its anesthetic property.

Business Type

Buildings and Property

Country

United States

Founded

2015
( 9 years old in 2024 )

Company Focus

Drug Research Program

Website

-

Corporate Office and Headquarter Office address:

1177 Avenue of the Americas
39th Floor
New York, NY 10036
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

post-traumatic stress disordersuicidalityketaminemedical officeits anesthetic property

* We use standard office opening hours in near Turing Pharmaceuticals (Intranasal Ketamine Program)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Turing Pharmaceuticals (Intranasal Ketamine Program) Frequently Asked Questions

What or who is Turing Pharmaceuticals (Intranasal Ketamine Program)?

Turing Pharmaceuticals (Intranasal Ketamine Program) is Buildings and Property business from United States that founded in 2015 (9 years old in 2024), Turing Pharmaceuticals (Intranasal Ketamine Program) business is focusing on Drug Research Program.

Where is Turing Pharmaceuticals (Intranasal Ketamine Program) headquarter and corporate office address?

Turing Pharmaceuticals (Intranasal Ketamine Program) headquarter office and corporate office address is located in 1177 Avenue of the Americas 39th Floor New York, NY 10036 United States.

Where is Turing Pharmaceuticals (Intranasal Ketamine Program) country origins?

Turing Pharmaceuticals (Intranasal Ketamine Program) was founded in United States.

What is Drug Research Program business focus on?

In 2024, Turing Pharmaceuticals (Intranasal Ketamine Program) is currently focus on drug research program sector.

Drug Research Program Business Interest from Google Trend

Above is snippet of Google Trends for "drug research program" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Turing Pharmaceuticals (Intranasal Ketamine Program), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.